Champalimaud Foundation adopts Lonza’s MODA-ES® Platform to streamline cell therapy manufacturing
August 13, 2024

August 13, 2024
June 11, 2024
May 25, 2023
April 20, 2023
December 6, 2022
September 6, 2022
August 4, 2022
May 24, 2022
May 3, 2022
October 6, 2026
Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences...
October 5, 2026
Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar...
October 1, 2026
The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225